ABSTRACT
Escherichia coli is the leading cause of urinary tract infections (UTIs), one of the most common infections in humans. P fimbria was arguably the first proposed virulence factor for uropathogenic E. coli, based on the capacity of E. coli isolated from UTIs to adhere to exfoliated epithelial cells in higher numbers than fecal strains of E. coli. Overwhelming epidemiologic evidence has been presented for involvement of P fimbriae in colonization. It has been difficult, however, to demonstrate this requirement for uropathogenic strains in animal models of infections or in humans. In this study, a signature-tagged mutagenesis screen identified a P-fimbrial gene (papC) and 18 other genes as being among those required for full fitness of cystitis isolate E. coli F11. A P-fimbrial mutant was outcompeted by the wild-type strain in cochallenge in the murine model of ascending UTI, and this colonization defect could be complemented with the cloned pap operon. To our knowledge, this study is the first to fulfill molecular Koch's postulates in which a pathogenic strain was attenuated by mutation of pap genes and then complemented to restore fitness, confirming P fimbria as a virulence factor in a pathogenic clinical isolate.
Subject(s)
Adhesins, Bacterial/metabolism , Bacterial Adhesion , Escherichia coli Infections/microbiology , Fimbriae, Bacterial/metabolism , Urinary Tract Infections/microbiology , Uropathogenic Escherichia coli/physiology , Virulence Factors/metabolism , Adhesins, Bacterial/genetics , Animals , Coinfection/microbiology , Disease Models, Animal , Fimbriae, Bacterial/genetics , Gene Deletion , Genetic Complementation Test , Genetic Testing , Mice , Mutagenesis , Operon , Uropathogenic Escherichia coli/genetics , Virulence Factors/geneticsABSTRACT
Uropathogenic Escherichia coli (UPEC), a member of extraintestinal pathogenic E. coli, cause â¼80% of community-acquired urinary tract infections (UTI) in humans. UPEC initiates its colonization in epithelial cells lining the urinary tract with a complicated life cycle, replicating and persisting in intracellular and extracellular niches. Consequently, UPEC causes cystitis and more severe form of pyelonephritis. To further understand the virulence characteristics of UPEC, we investigated the roles of BarA-UvrY two-component system (TCS) in regulating UPEC virulence. Our results showed that mutation of BarA-UvrY TCS significantly decreased the virulence of UPEC CFT073, as assessed by mouse urinary tract infection, chicken embryo killing assay, and cytotoxicity assay on human kidney and uroepithelial cell lines. Furthermore, mutation of either barA or uvrY gene reduced the production of hemolysin, lipopolysaccharide (LPS), proinflammatory cytokines (TNF-α and IL-6) and chemokine (IL-8). The virulence phenotype was restored similar to that of wild-type by complementation of either barA or uvrY gene in trans. In addition, we discussed a possible link between the BarA-UvrY TCS and CsrA in positively and negatively controlling virulence in UPEC. Overall, this study provides the evidences for BarA-UvrY TCS regulates the virulence of UPEC CFT073 and may point to mechanisms by which virulence regulations are observed in different ways may control the long-term survival of UPEC in the urinary tract.
Subject(s)
Escherichia coli Proteins/metabolism , Membrane Proteins/metabolism , Phosphotransferases/metabolism , Signal Transduction , Transcription Factors/metabolism , Uropathogenic Escherichia coli/pathogenicity , Animals , Biological Assay , Cell Death/drug effects , Cell Line , Cell Movement/drug effects , Chick Embryo , Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Down-Regulation/drug effects , Epithelial Cells/drug effects , Epithelial Cells/microbiology , Epithelial Cells/pathology , Escherichia coli Proteins/genetics , Gene Deletion , Hemolysin Proteins/metabolism , Hemolysis/drug effects , Humans , Lipopolysaccharides/pharmacology , Membrane Proteins/genetics , Mice , Mutation/genetics , Phosphotransferases/genetics , Sheep , Signal Transduction/drug effects , Transcription Factors/genetics , Urinary Tract Infections/microbiology , Urinary Tract Infections/pathology , Uropathogenic Escherichia coli/drug effects , Uropathogenic Escherichia coli/genetics , Virulence/drug effectsABSTRACT
BACKGROUND: Capsule expression may be important during ascending Escherichia coli urinary tract infections (UTIs). METHODS: An isogenic ksl(k2)ABCDE mutant of extraintestinal pathogenic E. coli (ExPEC) strain CFT073 that could not synthesize the K2 capsule was compared with wild-type CFT073, to determine virulence in a murine model of ascending UTI and in vitro killing assays. RESULTS: No significant differences were observed regarding the abilities of the mutant and the wild-type CFT073 strains to colonize the murine urinary tract in single-challenge infection experiments. However, in competitive-colonization experiments, the mutant was significantly outcompeted by the wild-type strain in urine and the kidneys. The mutant strain was also more susceptible to human serum. Complementation of the mutant with a plasmid containing the ksl(k2)ABCDE genes restored capsule expression, enhanced survival in the murine urinary tract, and restored serum resistance. CONCLUSION: These results indicate that expression of the K2 capsule is important for the pathogenesis of UTI and provides protection against complement-mediated killing. To our knowledge, this is the first study in which the E. coli capsule has been proven to play a role in infection by use of isogenic mutants and genetic complementation.
Subject(s)
Bacterial Capsules/genetics , Escherichia coli Infections/genetics , Escherichia coli/genetics , Escherichia coli/pathogenicity , Urinary Tract Infections/microbiology , Animals , Cloning, Molecular , Cosmids/genetics , DNA Primers , Disease Models, Animal , Escherichia coli Infections/blood , Humans , Mice , Mice, Inbred CBA , Molecular Sequence Data , Mutation , Plasmids , Sequence DeletionABSTRACT
The Gram-negative bacterium Proteus mirabilis causes urinary tract infections (UTIs) in individuals with long-term indwelling catheters or those with functional or structural abnormalities of the urinary tract. Known virulence factors include urease, haemolysin, fimbriae, flagella, DsbA, a phosphate transporter and genes involved in cell-wall synthesis and metabolism, many of which have been identified using the technique of signature-tagged mutagenesis (STM). To identify additional virulence determinants and to increase the theoretical coverage of the genome, this study generated and assessed 1880 P. mirabilis strain HI4320 mutants using this method. Mutants with disruptions in genes vital for colonization of the CBA mouse model of ascending UTI were identified after performing primary and secondary in vivo screens in approximately 315 CBA mice, primary and secondary in vitro screens in both Luria broth and minimal A medium to eliminate mutants with minor growth deficiencies, and co-challenge competition experiments in approximately 500 CBA mice. After completion of in vivo screening, a total of 217 transposon mutants were attenuated in the CBA mouse model of ascending UTI. Following in vitro screening, this number was reduced to 196 transposon mutants with a probable role in virulence. Co-challenge competition experiments confirmed significant attenuation for 37 of the 93 transposon mutants tested, being outcompeted by wild-type HI4320. Following sequence analysis of the 37 mutants, transposon insertions were identified in genes including the peptidyl-prolyl isomerases surA and ppiA, glycosyltransferase cpsF, biopolymer transport protein exbD, transcriptional regulator nhaR, one putative fimbrial protein, flagellar M-ring protein fliF and hook protein flgE, and multiple metabolic genes.
Subject(s)
Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Proteus mirabilis/pathogenicity , Urinary Tract Infections/microbiology , Virulence Factors/analysis , Animals , Cell Surface Extensions/physiology , DNA Transposable Elements/genetics , Gene Expression Regulation, Bacterial/physiology , Mice , Mice, Inbred CBA , Mutagenesis , Phenotype , Proteus mirabilis/genetics , Proteus mirabilis/physiology , Virulence , Virulence Factors/geneticsABSTRACT
Type 1 fimbrial phase-locked mutants of uropathogenic Escherichia coli cystitis isolate F11 were used to assess the role of the invertible element during urinary tract infection. Compared to the wild type, the phase-locked off mutant was attenuated, and constitutive production of type 1 fimbriae by the phase-locked on mutant did not provide a competitive advantage.
Subject(s)
Escherichia coli/classification , Escherichia coli/pathogenicity , Fimbriae, Bacterial/metabolism , Gene Expression Regulation, Bacterial , Urinary Tract Infections/microbiology , Animals , Colony Count, Microbial , Cystitis/microbiology , Escherichia coli/genetics , Escherichia coli/growth & development , Escherichia coli Infections/microbiology , Escherichia coli Proteins/genetics , Escherichia coli Proteins/metabolism , Female , Fimbriae, Bacterial/genetics , Humans , Kidney/microbiology , Mice , Mice, Inbred CBA , Mutation , Urinary Bladder/microbiology , Urine/microbiology , VirulenceABSTRACT
The phoU gene is the last cistron in the pstSCAB-phoU operon and functions as a negative regulator of the Pho regulon. The authors previously identified a phoU mutant of extraintestinal pathogenic Escherichia coli strain CFT073 and demonstrated that this mutant was attenuated for survival in the murine model of ascending urinary tract infection. It is hypothesized that the PhoU protein might serve as a urovirulence factor by indirectly affecting the expression of virulence-related genes. In this study, the phoU mutant was further characterized and PhoU was confirmed as a virulence factor. Western blot analysis demonstrated that insertion of the transposon in the phoU gene disrupted the expression of PhoU. The phoU mutant had derepressed alkaline phosphatase activity under phosphate-excess and -limiting conditions. In single-challenge murine ascending urinary tract infection experiments, quantitative cultures of urine, bladder and kidney revealed no significant differences between the phoU mutant strain and the wild-type strain CFT073. However, in competitive colonization experiments, the phoU mutant strain was significantly out-competed by the wild-type strain in the kidneys and urine and recovered in lower amount in the bladder. Complementation of the phoU mutant with a plasmid containing the wild-type phoU gene restored the expression of PhoU and alkaline phosphate activity to wild-type levels and no significant difference in colonization was observed between the phoU mutant containing the complementing plasmid and wild-type in competitive colonization experiments. In human urine, the phoU mutant and wild-type grew comparably when inoculated independently, indicating that the attenuation observed was not due to a general growth defect. However, as observed in vivo, the wild-type out-competed the phoU mutant in competition growth experiments in human urine. These data indicate that PhoU contributes to efficient colonization of the murine urinary tract and add PhoU to a short list of confirmed urovirulence factors.
Subject(s)
Escherichia coli Infections/microbiology , Escherichia coli Proteins/physiology , Escherichia coli/pathogenicity , Female Urogenital Diseases/microbiology , Male Urogenital Diseases , Membrane Transport Proteins/physiology , Transcription Factors/physiology , Virulence Factors/physiology , Alkaline Phosphatase/metabolism , Animals , Down-Regulation , Escherichia coli/metabolism , Escherichia coli Proteins/genetics , Humans , Kidney/microbiology , Membrane Transport Proteins/genetics , Mice , Mice, Inbred CBA , Transcription Factors/genetics , Urinary Bladder/microbiology , Urine/microbiology , Virulence/immunology , Virulence Factors/geneticsABSTRACT
Uropathogenic Escherichia coli is the most common etiological agent of urinary tract infections. Bacteria can often express multiple adhesins during infection in order to favor attachment to specific niches within the urinary tract. We have recently demonstrated that type 1 fimbria, a phase-variable virulence factor involved in adherence, was the most highly expressed adhesin during urinary tract infection. Here, we examine whether the expression of type 1 fimbriae can affect the expression of other adhesins. Type 1 fimbrial phase-locked mutants of E. coli strain CFT073, which harbors genes for numerous adhesins, were employed in this study. CFT073-specific DNA microarray analysis of these strains demonstrates that the expression of type 1 fimbriae coordinately affects the expression of P fimbriae in an inverse manner. This represents evidence for direct communication between genes relating to pathogenesis, perhaps to aid the sequential occupation of different urinary tract tissues. While the role of type 1 fimbriae during infection has been clear, the role of P fimbriae must be further defined to assert the relevance of coordinated regulation in vivo. Therefore, we examined the ability of P fimbrial isogenic mutants, constructed in a type 1 fimbrial-negative background, to compete in the murine urinary tract over a period of 168 h. No differences in the colonization of these mutants were observed. However, comparison of these results with previous studies suggests that inversely coordinated expression of adhesin gene clusters does occur in vivo. Interestingly, the mutant that was incapable of expressing either type 1 or P fimbriae compensated by synthesizing F1C fimbriae.
Subject(s)
Escherichia coli Proteins/biosynthesis , Escherichia coli/genetics , Escherichia coli/metabolism , Fimbriae Proteins/biosynthesis , Gene Expression Regulation, Bacterial , Animals , Disease Models, Animal , Escherichia coli/pathogenicity , Escherichia coli Infections/microbiology , Escherichia coli Proteins/genetics , Female , Fimbriae Proteins/genetics , Fimbriae, Bacterial/metabolism , Genotype , Mice , Mice, Inbred CBA , Mutation , Oligonucleotide Array Sequence Analysis , Urinary Tract Infections/microbiologyABSTRACT
This is a follow-up to our previous study using an intranasal vaccine composed of MrpH, the tip adhesin of the MR/P fimbria, and cholera toxin to prevent urinary tract infection by Proteus mirabilis (X. Li, C. V. Lockatell, D. E. Johnson, M. C. Lane, J. W. Warren, and H. L. Mobley, Infect. Immun. 72:66-75, 2004). Here, we have expressed a cholera toxin-like chimera in which the MrpH adhesin-binding domain (residues 23 to 157) replaces the cholera toxin A1 ADP-ribosyltransferase domain. This chimera, when administered intranasally without additional adjuvant, is sufficient to induce protective immunity in mice.
Subject(s)
Adhesins, Bacterial/immunology , Bacterial Vaccines/immunology , Cholera Toxin/immunology , Fimbriae Proteins/immunology , Proteus Infections/prevention & control , Proteus mirabilis/immunology , Recombinant Fusion Proteins/immunology , Urinary Tract Infections/prevention & control , Vaccines, Synthetic/immunology , Adhesins, Bacterial/chemistry , Administration, Intranasal , Animals , Binding Sites , Fimbriae Proteins/chemistry , Mice , Protein Biosynthesis , VaccinationABSTRACT
A uropathogenic Escherichia coli strain CFT073-specific DNA microarray that includes each open reading frame was used to analyze the transcriptome of CFT073 bacteria isolated directly from the urine of infected CBA/J mice. The in vivo expression profiles were compared to that of E. coli CFT073 grown statically to exponential phase in rich medium, revealing the strategies this pathogen uses in vivo for colonization, growth, and survival in the urinary tract environment. The most highly expressed genes overall in vivo encoded translational machinery, indicating that the bacteria were in a rapid growth state despite specific nutrient limitations. Expression of type 1 fimbriae, a virulence factor involved in adherence, was highly upregulated in vivo. Five iron acquisition systems were all highly upregulated during urinary tract infection, as were genes responsible for capsular polysaccharide and lipopolysaccharide synthesis, drug resistance, and microcin secretion. Surprisingly, other fimbrial genes, such as pap and foc/sfa, and genes involved in motility and chemotaxis were downregulated in vivo. E. coli CFT073 grown in human urine resulted in the upregulation of iron acquisition, capsule, and microcin secretion genes, thus partially mimicking growth in vivo. On the basis of gene expression levels, the urinary tract appears to be nitrogen and iron limiting, of high osmolarity, and of moderate oxygenation. This study represents the first assessment of any E. coli pathotype's transcriptome in vivo and provides specific insights into the mechanisms necessary for urinary tract pathogenesis.
Subject(s)
Escherichia coli Proteins/metabolism , Escherichia coli/pathogenicity , Proteome , Transcription, Genetic , Urinary Tract Infections/microbiology , Animals , Culture Media , Escherichia coli/genetics , Escherichia coli/metabolism , Escherichia coli Infections/microbiology , Escherichia coli Proteins/genetics , Gene Expression Regulation, Bacterial , Humans , Mice , Mice, Inbred CBA , Oligonucleotide Array Sequence Analysis , Open Reading Frames , Species Specificity , Urine/microbiologyABSTRACT
Proteus mirabilis, a common cause of urinary tract infections (UTI) in individuals with functional or structural abnormalities or with long-term catheterization, forms bladder and kidney stones as a consequence of urease-mediated urea hydrolysis. Known virulence factors, besides urease, are hemolysin, fimbriae, metalloproteases, and flagella. In this study we utilized the CBA mouse model of ascending UTI to evaluate the colonization of mutants of P. mirabilis HI4320 that were generated by signature-tagged mutagenesis. By performing primary screening of 2088 P. mirabilis transposon mutants, we identified 502 mutants that ranged from slightly attenuated to unrecoverable. Secondary screening of these mutants revealed that 114 transposon mutants were reproducibly attenuated. Cochallenge of 84 of these single mutants with the parent strain in the mouse model resulted in identification of 37 consistently out-competed P. mirabilis transposon mutants, 25 of which were out-competed >100-fold for colonization of the bladder and/or kidneys by the parent strain. We determined the sequence flanking the site of transposon insertion in 29 attenuated mutants and identified genes affecting motility, iron acquisition, transcriptional regulation, phosphate transport, urease activity, cell surface structure, and key metabolic pathways as requirements for P. mirabilis infection of the urinary tract. Two mutations localized to a approximately 42-kb plasmid present in the parent strain, suggesting that the plasmid is important for colonization. Isolation of disrupted genes encoding proteins with homologies to known bacterial virulence factors, especially the urease accessory protein UreF and the disulfide formation protein DsbA, showed that the CBA mouse model and mutant pools are a reliable source of attenuated mutants with mutations in virulence genes.
Subject(s)
Genes, Bacterial , Proteus Infections/etiology , Proteus mirabilis/genetics , Proteus mirabilis/pathogenicity , Urinary Tract Infections/etiology , Animals , Base Sequence , Culture Media , DNA, Bacterial/genetics , Escherichia coli/genetics , Escherichia coli/pathogenicity , Female , Humans , Iron/metabolism , Mice , Mice, Inbred CBA , Mutagenesis , Mutation , Phenotype , Plasmids/genetics , Polysaccharides, Bacterial/biosynthesis , Proteus Infections/microbiology , Proteus mirabilis/growth & development , Proteus mirabilis/metabolism , Species Specificity , Urinary Tract Infections/microbiology , Virulence/geneticsABSTRACT
Proteus mirabilis commonly infects the complicated urinary tract and is associated with urolithiasis. Stone formation is caused by bacterial urease, which hydrolyzes urea to ammonia, causing local pH to rise, and leads to the subsequent precipitation of magnesium ammonium phosphate (struvite) and calcium phosphate (apatite) crystals. To prevent these infections, we vaccinated CBA mice with formalin-killed bacteria or purified mannose-resistant, Proteus-like (MR/P) fimbriae, a surface antigen expressed by P. mirabilis during experimental urinary tract infection, via four routes of immunization: subcutaneous, intranasal, transurethral, and oral. We assessed the efficacy of vaccination using the CBA mouse model of ascending urinary tract infection. Subcutaneous or intranasal immunization with formalin-killed bacteria and intranasal or transurethral immunization with purified MR/P fimbriae significantly protected CBA mice from ascending urinary tract infection by P. mirabilis (P < 0.05). To investigate the potential of MrpH, the MR/P fimbrial tip adhesin, as a vaccine, the mature MrpH peptide (residues 23 to 275, excluding the signal peptide), and the N-terminal receptor-binding domain of MrpH (residues 23 to 157) were overexpressed as C-terminal fusions to maltose-binding protein (MBP) and purified on amylose resins. Intranasal immunization of CBA mice with MBP-MrpH (residues 23 to 157) conferred effective protection against urinary tract infection by P. mirabilis (P < 0.002).
Subject(s)
Bacterial Vaccines/administration & dosage , Proteus Infections/prevention & control , Proteus mirabilis/immunology , Urinary Tract Infections/prevention & control , Adhesins, Bacterial/genetics , Adhesins, Bacterial/immunology , Administration, Intranasal , Animals , Antibodies, Bacterial/blood , Bacterial Vaccines/immunology , Fimbriae Proteins/genetics , Fimbriae Proteins/immunology , Formaldehyde/pharmacology , Immunization , Mice , Mice, Inbred CBA , Proteus Infections/microbiology , Proteus mirabilis/growth & development , Urinary Tract Infections/microbiology , Vaccines, DNA/administration & dosage , Vaccines, DNA/immunology , Vaccines, Inactivated/administration & dosage , Vaccines, Inactivated/immunologyABSTRACT
We have identified two chromosomal open reading frames in uropathogenic Escherichia coli (UPEC) strain CFT073 which are highly homologous to serine protease autotransporters Pic and Tsh. Both cloned determinants were correlated with the presence of 105- to 110-kDa proteins in the culture supernatants. Furthermore, in cellular fractionation experiments, 30-kDa polypeptides were identified in the outer membrane; we speculated that these proteins are the beta-barrel portions of the autotransporter homologues. Furthermore, Pic-containing culture supernatants have serine protease activity. In reverse transcription-PCR analyses, the expression of the pic and tsh genes in E. coli CFT073 was higher in broth cultures grown at 37 degrees C than at 25 degrees C. Moreover, pic and tsh were expressed by bacteria isolated from urine of transurethrally infected mice. The tsh determinant was identified in 63% of our clinical UPEC strain isolates (n = 87) and in 33% of fecal strains (n = 27), whereas pic was present in 31% of the pyelonephritis (n = 67) and 7% of the fecal strains. There was no significant correlation between cystitis strains (n = 20) and the pic determinant.
Subject(s)
Adhesins, Escherichia coli/metabolism , Escherichia coli/pathogenicity , Hemagglutinins/metabolism , Polysaccharide-Lyases/metabolism , Protein Transport , Pyelonephritis/microbiology , Urinary Tract Infections/microbiology , Acute Disease , Adhesins, Escherichia coli/genetics , Animals , Disease Models, Animal , Escherichia coli/genetics , Escherichia coli Infections/microbiology , Gene Expression Regulation, Bacterial , Hemagglutinins/genetics , Mice , Mice, Inbred CBA , Polysaccharide-Lyases/genetics , Serine Endopeptidases/genetics , Serine Endopeptidases/metabolism , Urine/microbiology , VirulenceABSTRACT
The alarming rate of bacterial resistance induction highlights the clinical need for antimicrobial agents that act by novel modes of action. Based on the activity profile, the general tissue distribution and renal clearance of peptide-based drugs, we hypothesized that our newly developed pyrrhocoricin derivative would be able to fight resistant uropathogens in vitro and in vivo. Indeed, the Pip-pyrr-MeArg dimer killed all 11 urinary tract infection-related Escherichia coli and Klebsiella pneumoniae strains we studied in the sub-low micromolar concentration range. Almost all control antibiotics, including the currently leading trimethoprim-sulfametoxazole combination for urinary tract infection, remained without considerable activity against two or more of these bacterial strains. In a mouse ascending urinary tract infection model with E. coli CFT073 as pathogen, two doses of intravenous, subcutaneous or oral treatment with the Pip-pyrr-MeArg derivative reduced the bacterial counts in the kidneys, bladder and urine to varying levels. Statistically significant elimination or reduction of bacteria compared to untreated animals was observed at dual intravenous or subcutaneous doses of 0.4 or 10mg/kg, respectively. Serial passage of the same E. coli strain in the presence of sublethal doses of the designed peptide failed to generate resistant mutants. The Pip-pyrr-MeArg dimer showed no toxicity to COS-7 cells to the highest 500microM concentration studied.
Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Infective Agents, Urinary/pharmacology , Peptides/pharmacology , Urinary Tract Infections/drug therapy , Urinary Tract Infections/microbiology , Administration, Oral , Amino Acid Sequence , Animals , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/chemistry , Anti-Infective Agents, Urinary/administration & dosage , Anti-Infective Agents, Urinary/chemistry , Drug Resistance, Bacterial , Escherichia coli/drug effects , Escherichia coli Infections/drug therapy , Escherichia coli Infections/microbiology , Female , Injections, Intravenous , Injections, Subcutaneous , Klebsiella Infections/drug therapy , Klebsiella Infections/microbiology , Klebsiella pneumoniae/drug effects , Mice , Molecular Sequence Data , Peptides/administration & dosage , Peptides/chemistryABSTRACT
Proteus mirabilis, a common cause of nosocomial and catheter-associated urinary tract infection, colonizes the bladder and ascends the ureters to the proximal tubules of the kidneys, leading to the development of acute pyelonephritis. P. mirabilis is capable of swarming, a form of multicellular behavior in which bacteria differentiate from the short rod typical of members of the family Enterobacteriaceae, termed the swimmer cell, into hyperflagellated elongated bacteria capable of rapid and coordinated population migration across surfaces, called the swarmer cell. There has been considerable debate as to which morphotype predominates during urinary tract infection. P. mirabilis(pBAC001), which expresses green fluorescent protein in both swimming and swarming morphotypes, was constructed to quantify the prevalence of each morphotype in ascending urinary tract infection. Transurethral inoculation of P. mirabilis(pBAC001) resulted in ascending urinary tract infection and kidney pathology in mice examined at both 2 and 4 days postinoculation. Using confocal microscopy, we were able to investigate the morphotypes of the bacteria in the urinary tract. Of 5,087 bacteria measured in bladders, ureters, and kidneys, only 7 (0.14%) were identified as swarmers. MR/P fimbria expression, which correlates with the swimmer phenotype, is prevalent on bacteria in the ureters and bladder. We conclude that, by far, the predominant morphotype present in the urinary tract during ascending infection is the short rod-the swimmer cell.
Subject(s)
Proteus mirabilis/cytology , Urinary Tract Infections/microbiology , Urinary Tract/microbiology , Animals , Disease Models, Animal , Female , Fimbriae, Bacterial/physiology , Humans , Mice , Mice, Inbred CBA , Proteus mirabilis/isolation & purification , Ureter/microbiologyABSTRACT
Proteus mirabilis, a cause of complicated urinary tract infection, produces urease, an essential virulence factor for this species. UreR, a member of the AraC/XylS family of transcriptional regulators, positively activates expression of the ure gene cluster in the presence of urea. To specifically evaluate the contribution of UreR to urease activity and virulence in the urinary tract, a ureR mutation was introduced into P. mirabilis HI4320 by homologous recombination. The isogenic ureR::aphA mutant, deficient in UreR production, lacked measurable urease activity. Expression was not detected in the UreR-deficient strain by Western blotting with monoclonal antibodies raised against UreD. Urease activity and UreD expression were restored by complementation of the mutant strain with ureR expressed from a low-copy-number plasmid. Virulence was assessed by transurethral cochallenge of CBA mice with wild-type and mutant strains. The isogenic ureR::aphA mutant of HI4320 was outcompeted in the urine (P = 0.004), bladder (P = 0.016), and kidneys (P < or = 0.001) 7 days after inoculation. Thus, UreR is required for basal urease activity in the absence of urea, for induction of urease by urea, and for virulence of P. mirabilis in the urinary tract.
Subject(s)
Bacterial Proteins/metabolism , Multigene Family , Proteus mirabilis/pathogenicity , Trans-Activators/metabolism , Urease/metabolism , Urinary Tract Infections/microbiology , Animals , Bacterial Proteins/genetics , Female , Gene Expression Regulation, Bacterial , Mice , Mice, Inbred CBA , Mutation , Proteus Infections/microbiology , Proteus mirabilis/enzymology , Proteus mirabilis/genetics , Trans-Activators/genetics , Urea/metabolism , VirulenceABSTRACT
Proteus mirabilis is a common cause of urinary tract infection (UTI) in individuals with structural abnormalities or long-term catheterization. The expression of mannose-resistant/Proteus-like (MR/P) fimbria is phase variable because of the inversion of a 251 bp DNA fragment that carries the promoter for the mrp operon. Previous studies have shown that mrpI, which is transcribed divergently from the mrp operon, encodes a recombinase capable of switching the orientation of this invertible element. In this study, we constructed isogenic mrpI null mutants from a clinical isolate of P. mirabilis, HI4320. A polymerase chain reaction (PCR)-based invertible element assay revealed that the isogenic mrpI null mutants were locked in one phase, either expressing (locked on) MR/P fimbriae or not (locked off), which indicated that MrpI was the sole recombinase that regulated the phase variation of MR/P fimbria. The locked-on and locked-off mutants were evaluated for virulence in the CBA mouse model of ascending UTI by co-challenges with each other and with the wild-type strain. Results from these experiments demonstrated conclusively that the MR/P fimbria was a critical bladder colonization factor of uropathogenic P. mirabilis and also suggested that the ability to switch off the expression of MR/P fimbria might be important for kidney colonization.
Subject(s)
DNA Nucleotidyltransferases/physiology , Fimbriae, Bacterial/metabolism , Mannose/metabolism , Proteus Infections/metabolism , Proteus mirabilis/physiology , Animals , Bacterial Proteins , Fimbriae, Bacterial/genetics , Gene Expression Regulation, Bacterial , Genetic Complementation Test , Kidney/microbiology , Mice , Mice, Inbred CBA , Models, Animal , Molecular Sequence Data , Polymerase Chain Reaction , Proteus Infections/microbiology , Proteus mirabilis/genetics , Proteus mirabilis/pathogenicity , Recombinases , Urinary Bladder/microbiologyABSTRACT
Quorum sensing regulates the expression of virulence factors in a wide variety of pathogenic bacteria. This study has shown that Proteus mirabilis harbours a homologue of luxS, a gene required for the synthesis of the quorum sensing autoinducer 2 (AI-2). AI-2 activity is expressed during and is correlated with the initiation of swarming migration on agar surfaces. The P. mirabilis luxS locus was cloned and a LuxS(-) strain constructed by allelic-exchange mutagenesis. While lacking AI-2 activity, a null mutation in luxS, however, did not affect swimming or swarming motility, swarmer cell differentiation, or virulence in a mouse model of ascending urinary tract infection.
Subject(s)
Bacterial Proteins/genetics , Gene Expression Regulation, Bacterial , Homoserine/analogs & derivatives , Homoserine/genetics , Homoserine/metabolism , Lactones/metabolism , Proteus mirabilis/physiology , Proteus mirabilis/pathogenicity , Animals , Bacterial Proteins/metabolism , Carbon-Sulfur Lyases , Female , Mice , Molecular Sequence Data , Mutation , Proteus Infections/microbiology , Signal Transduction , Urinary Tract Infections/microbiology , VirulenceABSTRACT
The virulence of a urease-negative mutant of uropathogenic Proteus mirabilis and its wild-type parent strain was assessed by using a CBA mouse model of catheterized urinary tract infection. Overall, catheterized mice were significantly more susceptible than uncatheterized mice to infection by wild-type P. mirabilis. At a high inoculum, the urease-negative mutant successfully colonized bladders of catheterized mice but did not cause urolithiasis and was still severely attenuated in its ability to ascend to kidneys. Using confocal laser scanning microscopy and scanning electron microscopy, we demonstrated the presence of P. mirabilis within the urease-induced stone matrix. Alizarin red S staining was used to detect calcium-containing deposits in bladder and kidney tissues of P. mirabilis-infected mice.